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Summary.-Resistance can be induced in the syngeneic host (August rats) to a
myelogeneous leukaemia of spontaneous origin, called SAL, by immunization with
allogeneic cells derived from both normal and malignant tissues obtained from the
Hooded rat strain. Serological experiments support the conclusion that the antigen
involved-referred to as "Ho-SAL"-has the properties of a tumour specific trans-
plantation-type antigen for SAL cells but is a widely expressed alloantigen found in
both normal and malignant cells derived from Hooded rats. Antisera to it can be
raised in Wistar rats.
THE preceding paper (Wrathmell,
1976) described the growth pattern of a
transplantable acute myeloid leukaemia
of rats, referred to as SAL. Attempts to
induce rejection or even to delay the rate
ofgrowth ofthis transplantable leukaemia
by prior hyperimmunization of syngeneic
recipients with irradiated leukaemia cells
or by stimulation with BCG or Coryne-
bacteritum parvum were unsuccessful
(Wrathmell and Alexander, 1973) and the
only indication for the presence of a
tumour specific transplantation-type anti-
gen (TSTA) on SAL cells came from
experiments in which specifically immune
thoracic duct cells were effective as
immunotherapy (Wrathmell and Alex-
ander, 1973) and from an investigation
(Wrathmell and Alexander, 1976) in which
hyperimmunization with mitomycin-C
treated SAL cells slowed the growth of
subsequently inoculated SAL cells.
We now report that marked resistance
to SAL can be induced by immunizing
syngeneic August rats with a variety of
cells from rats ofthe Hooded strain.* This
observation arose from an experiment in
which August rats were immunized with
leukaemic cells (referred to as " HRL ")
which had arisen spontaneously in a
Hooded rat. This initial experiment was
designed to test whether SAL and HRL
shared a TSTA and whether a host res-
ponse might be facilitated by presenting
a TSTA on an allogeneic background.
HRL cells when inoculated into August
rats (in which they do not grow) gave
increased protection against a challenge
ofSAL. A similar effect couldbe achieved
with normal cells from Hooded rats.
Other investigators (Chang et al., 1972
Katz et al., 1972; Kobayashi et al., 1974;
Invernizzi and Parmiani, 1975) have
rendered rodents more resistant to syn-
geneic tumours by immunizing with allo-
geneic normal cells. In different situa-
tions, this effect had been attributed
either to the cross reaction of the TSTA
of the tumour cell with an alloantigen of
the allogeneic cells (Chang et al., 1972;
Invernizzi and Parmiani, 1975) or to
non-specific stimulation of the immune
responsiveness of the host (Katz et al.,
1972; Kobayashi et al., 1974). In an
* August and Hooded strains share the major histocompatability locus Ag-B5 but reject inter-strain skin
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experiment using guinea-pigs, protection
by allogeneic lymphoid cells against a
syngeneic leukaemia was attributed (Katz
et at., 1972; Ellman et al., 1972) to the
establishment of a graft-versus-host reac-
tion which potentiates immune reactivity
(a phenomenon referred to as "the allo-
geneic effect"), while in rats protection
against a sarcoma was attributed to non-
specific stimulation of the reticuloendothe-
lial system by repeatedly administered
allogeneic cells (Kobayashi et al., 1974).
The TL antigens (Boyse, Old and Luell,
1963; Boyse, Old and Stockert, 1965),
the MM antigen (Chang et al., 1972) and
Glx antigen (Stockert, Old and Boyse,
1971) are membrane constituents which
in certain mouse strains occur only on
syngeneic leukaemia cells (or for MM
also on some mammary carcinoma cells)
butin other mouse strains are a component
of normal lymphoid cells. However, im-
munization with allogeneic TL or Glx
positive thymocytes of TL or Glx nega-
tive mouse strains does not induce resis-
tance to challengewith TL or Glx positive
leukaemia cells although MM positive
lymphocytes may protect against MM
positive mammary carcinomata. The ex-
periments to be reported indicate that a
situation similar to TL, Glx and MM
could apply to the TSTA of the August
leukaemia SAL except that (1) the antigen
responsible induces resistance and (2)
the expression of the cross-reacting allo-
antigen is not confined to the lymphocytes
from Hooded rats and it has been detected
on a number of different cell types of
Hooded phenotype.
MATERIALS AND METHODS
Rats.-Pure line August, Hooded and
Wistar rats were obtained from the Institute's
breeding colony. August and Hooded rats
are histocompatible for the locus Ag-B5,
while the Wistar rat is Ag-B2. August x
Hooded F1 and August x Marshall F1 rats
were obtained by mating August females
with Hooded and Marshall males.
Tumours.-SAL is an acute leukaemia of
"myeloid " type syngeneic in female August
rats in which it arose spontaneously. HRL
is an acute spontaneous leukaemia of lym-
phoid type syngeneic in male Hooded rats
(Wrathmell, 1976). HSN is a benzpyrene-
induced fibrosarcoma syngeneic in female
Hooded rats. Transplantation of the leu-
kaemias was via buffy coat cells from the
blood of leukaemia rats injected intraven-
ously into recipient rats. HSN fibrosarcoma
was transplanted intramuscularly using
0-1 ml of tumour mush produced by passage
through a sieve.
Celt suspensions.-Spleen and thymus cell
suspensions were prepared by gently squeez-
ingthetissuewithforceps into TC 199. HRL
and SAL cells for immunization purposes
were obtained from the spleens of leukaemic
animals. Liver cell suspensions were pre-
pared from exsanguinated rats.
Embryonic cetls.-10-day foetuses were
broken up by passing through a sieve. X-
irradiated material was used for the first
immunization; non-irradiated material for
the second.
Cultured fibrobtasts.-Cultured fibroblasts
were obtained by gentle trypsinization from a
line which had been subcultured a number of
times and which did not cause tumours on
inoculation into syngeneic rats.
Immunization.-Rats were immunized
twice at 10-day intervals at 4 sites sub-
cutaneously and i.p. Equal amounts of
antigen were injected per site, each animal
receiving in total 5x 107 cells in sus-
pension or 0-5ml of tumour mush. Rats
were challenged 10 days after the second
immunization. X-irradiated cells used for
immunizationweregiven6000radx-raysfrom
aMarconix-raymachine220kV (nofilter) at a
dose rate of800 rad/min. Mitomycin treated
cells were incubated at a concentration of 107
cells/ml with 10 ,ug of mitomycin-C at 3700
for 30 min.
Antisera.-Wistar rats immunized with
Hooded spleen cells as outlined above were
bled 10 days after the second immunization.
The Wistar anti-SAL serum was raised by
coating the SAL cells with Wistar anti-
August spleen sera before injection into
Wistar rats. Syngeneic August anti-SAL
sera were raised byinoculating mitomycin-C-
treated SAL cells 3 times at 10-dayintervals.
Absorption of antisera.-All in vitro
absorptions were carried out at 40C for 1 h,
following which the sera were passed through
0-45 ,m millipore filters and centrifuged for
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15 minat 10,000g. Two mlof a 1: 5dilution of
Wistar anti-Hooded spleen cell serum was
absorbed with bone marrow, thymus, brain
and spleen cells from 4 normal adult August
rats and the bone marrow and spleen cells
from 2 normal adult Wistar rats. It was
also absorbed successively on 4 monolayers
containing 107 Wistar macrophages.
Two ml ofthe Wistar anti-SAL serum was
injected intraperitoneally in a normal adult
maleAugust rat and bled 4hlater. Twomlof
this serum was then absorbed with normal
August cells and with Wistar macrophages,
bone marrow and spleen as described.
The August anti-mitomycin-C treated
SAL cell serum was absorbed with Wistar
tissues as described above.
Measurement of membrane immunofluores-
cence.-All sera were tested against viable
target cells bytheindirectsandwichtechnique
at 4°C. The test sera were added for 30 min.
This was followed by 3 washes with cold
medium 199, after which the goat anti-rat
Ig fluorescent conjugate (supplied by Nordic)
was used at a dilution of 1/30 at which con-
centration it did not cause detectable
fluorescence ofthe target cells. The labelled
cells were examined byepi-illumination froma
caesium-iodide light source in a Zeiss photo-
microscope III fitted with planapochromatic
objectives. The fine speckled membrane fluo-
rescence was scored at a magnification of620.
Theendpointwastakenasthelowestdilutionof
serum giving positive membrane fluorescence.
Detection ofantibody by reducing migration
of SAL cells.-The procedure used involved
themeasurementofmigrationfrom a capillary
tube as described by Currie and Sime (1973).
The cells were preincubated with the sera at
different dilutions for 45 min at 4°C, then
washed and migrated into 10% heat inacti-
vated foetal calfserum in RPM1. Quadrupli-
cates were carried out for each serum dilution
and the dilution that gave 30% inhibition
was derived from the titration curve and
taken as the end-point.
RESULTS
Resistance to SAL leukaemia induced by
cellsfrom Hooded rats
Table I shows that immunization with
different cell types of Hooded phenotype,
malignant as well as normal, protects
August rats against a subsequent i.p.
challenge with 100 SAL cells. In un-
treated August rats this cell dose is
invariably fatal in less than 20 days and
protection is manifested both by prolonga-
TABLE I.-Resistance ofAugust Rats to a Challenge ofSyngeneicSAL leukaemiafollowing
Immunization with Allogeneic Cells
Immunization
None
Syngeneic August cells
Spleen
X-irradiated SAL
Allogeneic Wistar Cells
Spleen
Liver
Thymocytes
X-irradiated thymocytes
Allogeneic Hooded Cells
HRL leukaemia
X-irradiated HRL
Spleen cells
X-irradiated spleen cells
Thymocytes
Liver
Fibrosarcoma HSN
Foetal cells
Cultured fibroblasts
Hybrid Cells
August x Hooded F
spleen cells
August x Marshall Fl
spleen cells
No. of
animals
Survival times (days)
<20 -0 5
<20 20-50 >501
24 24 - -
6
9
10
9
9
8
23
9
10
9
5
10
9
7
7
10
11
6
8 1
7 3
7 2
7 2
8
11
6
4
3
3
4
5
6
1
3
5
1
6
2
2
5
2
- 11
6
2
3
1
4
1
3
2
8
13
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tion of life and by rats that survive for
more than 60 days free of disease. The
extension of life induced by immunization
with cells of both Wistar and Marshall
phenotype and SAL cells exposed to
x-rays is minimal, but highly significant
resistance to challenge is induced by
immunization with Hooded lymphoid cells
as well'as by Hooded liver cells, and cells
obtained from a Hooded sarcoma. While
it is possible that both the liver and
sarcoma cells may contain a small number
of lymphocytes, the finding that cultured
Hooded fibroblasts also protected estab-
lishes that the protective antigen is not
confined to lymphocytes. Irradiation did
not abolish the protective action of
Hooded leukaemia (HRL)* or Hooded
spleen cells.
In the experiments shown in Table I,
the SAL cells were inoculated i.p. but in
another series equally good protection
wasprovided against i.v. and s.c. challenge
of August rats with SAL cells following
immunization with HRL leukaemia cells.
Inability to demonstrate protection by an
"allogeneic effect "
The protection observed following
immunization with non-lymphoid Hooded
cells and by irradiated Hooded spleen
cells cannotbe attributedto stimulation by
an " allogeneic " effect as described by
Ellman et al. (1972) since such cells would
be unable to induce a graft-versus-host
reaction. The possibility that a graft-
versus-host reaction may be responsible
for the resistance induced by viable
Hooded lymphoid cells was excluded by
immunization of August rats with spleen
cells from F1 hybrids (August x Hooded).
Such spleen cells cannot induce a graft-
versus-host reaction in an August rat but
carry Hooded antigens and will therefore
induce immunity to such antigens. The
finding (see Table I) that the protection
provided by the F1 (August x Hooded)
spleen cells is as good as, if not better
than, that induced by Hooded spleen cells
is consistent with the view that the pro-
tection is due to the induction of specific
immunity to an alloantigen of Hooded
phenotype rather than stimulation of the
host by a graft-versus-host reaction.
Immunization with Wistar spleen cells
and August x Marshall F1 spleen cells
was less effective in protecting against a
challenge of SAL, suggesting that the
Hooded " component " is more important
than a host-versus-graft reaction. This
is further confirmed by the reverse experi-
ment in which F1 August x Hooded rats
immunized with either Hooded or August
spleen showed no increased resistance to
challenge with SAL. (SAL cells grow as
well in August x Hooded F1 hybrids as in
August rats.) In this situation a graft-
versus-host reaction should occur while
there would be no immunological reaction
to the cells used for immunization (either
Hooded or August). The SAL rat leu-
kaemia, therefore, differs from the guinea-
pig leukaemia (Katz et al., 1972; Ellman
et al., 1972) in which protection occurs
only following inoculation with cells that
can induce a graft-versus-host reaction.
Serological evidence for cross reaction be-
tween the TSTA of SAL and a membrane
antigen in Hooded cells
The induction ofresistance to SAL by a
variety of normal and malignant Hooded
cells is consistent with the hypothesis that
the SAL cells express on their surface an
antigenic determinant which is absent
from the normal cells of adult August rats
but which is present on many normal and
malignant cells of Hooded rats. Since
immunization of August rats with spleen
cells from Wistar rats and August x
Marshall F1 hybrid rats does not evoke
such strong immunity to SAL cells, we
feel justified in referring to the antigen as
Ho-SAL. While we were unable to
demonstrate cytotoxicity to SAL cells
using various sources of complement and
the trypan blue exclusion method with
antisera raised against SAL cells either in
*No protection against HRL cells injected into syngeneic Hooded rats could be induced with cells from
Wistar or August rats.
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syngeneic August rats or in Wistar rats
following thorough absorption with normal
August tissue, antibody was found in these
sera as well as in the sera of Wistar rats
immunized with Hooded cells (and then
absorbed by August tissue) by indirect
irnmunofluoresence and by migration in-
hibition (see Tables II and III).
In order to be sure that the binding of
antibody to SAL cells is specific, it is
necessary to remove from the test serum
immune complexes or aggregated immuno-
globulins since the SAL cells have recep-
tors that bind complexes or aggregates.
For this reason the alloantisera raised in
Wistar rats which have been rendered
specific for SAL by exhaustive absorption
with normal August tissues had then to
be freed of such complexes. This was
done by absorbing the absorbed sera on
Wistar myeloid cells, spleen cells and
macrophages until the sera no longer
bound to Wistar macrophages (Table IV).
Two types of absorbed allosera and a
syngeneic hyperimmune serum were tested
by immunfluorescence (see Table II):
(a) Sera from Wistar rats immunized
with SAL cells after absorption against
normal August tissues, in vivo and in
vitro, would be expected to react only with
TABLE II.--Detection of Ho-SAL by Indirect Immunofluorescence using Allo- and
Syngeneic Sera
Lowest concentration ofabsorbed antiserum
staining more than 80% of target cells
,__
Target cells
Autgtust
Leuikaemia SAL
Thymocytes
Bone marrow cells
Macrophages
Hooded
Letukaemia HRL
Thymocvtes
Bone marrow cells
HSN (cultured)
Fibiroblasts (cultured)
Foetal cells (cultured)
AMacrophages
Wistar
Thymocytes
Macrophages
Wistar aniti-
Wistai Hooded spleen
aniti-SAL cell serum
1/160*t
<1/2
1/5
1/5
1/160
1/80
1/80
1/80t
1/80
1/5
1/80
<1/1
<1/5
1/40*t
1/5
1/5
1/5
1/80
1/40T
1/40
1/40t
1/40
< 1/5
1/40
<1/1
<1/5
August
anti-SAL
1/40
< 1/1
< 1/1
1/2
1/20
1/lot
1/20
1/40t
1/40
1/20
1/20
<1/5
* Followvinig absorption with normal Hooded spleen cells, or thymocytes or bone marrow cells the titre
fell to 1/5.
t Following absorption with SAL cells the titre fell to 1/5.
t Following absorption with SAL cells the titre remainied unchanged.
TABLE III. Detection of Ho-Sal Antigen by Migration Inhibition using Allo-antisera*
Lowest concentration of absorbed allo-
antisera which produced 30% inhibition
of migration
Wistar anti-SAL Wistar anti-Hooded
Miigrating cell sertum spleen cell serum
August
Leukaemia SAL
Thymocytes
Hooded
Thymocytes
Wistar
1/80
< 1/5
1/100
1/30
<1/5
1/80
Thymocytes < 1/5 < 1/5
* Normal August serum and normal Wistar serum tested at 1/5-1/80 dilutions did not produce inhib-
ition of migration of greater than 5% compared with the foetal calf serum controls.
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TABLE IV. Evidence for the Removal of Soluble Immune Complex fromn Test Antisera
by Absorption against Wistar Rat Cells which Carry Fc Receptors
Sera teste(1
Rabbit anti-rat IgG
Rat IgG
Ag/Ab complexl
Aftei absorptiont
Wistar anti-Hoodted spleen
cell serum
After absorptiont
Wistar anti-SAL
After absorptiont
August anti-SAL
After absorptiont
Lowest (lilution giving membrane
immunofluorescence on macrophage
monolayers*
C-
Wistar August Hooded
1/1 1/1 1/1
1/40 1/40 1/40
1/160 1/32() 1/160
1/5 1/10 1/5
1/80
1/5
1/160
1/5
1/160
1/2
1/160
1/5
1/160
1/5
1/40
1/2
1/160
1/40
1/160
1/80
1/80
1/20
* Peritoneal exu(date cells wzere cuiltturedl for 18 h and then treate(l with trypsin. Following addition
of the test serum the presence of surface Ig was determined by indirect immunofluorescence writh either a
Goat anti-rat Ig FITC 1/30 or a goat anti-rabbit Ig FITC 1/60 conjugate (Nordic).
t Absorbe(d wvith bone marrow, spleen and peritoneal exudate cells and monolayers of Wistar macro-
phagess.
t Produce(d by mixing at equivalence rat IgG with rabbit aniti-rat IgG seium.
tumour specific antigens present in SAL
cells. To obtain such a serum, the tech-
nique described by Weiner, Hubbard and
Mardiney (1972) was used in which the
SAL cells were coated before inoculation
into Wistar rats with Wistar anti-August
spleen cell alloantibody. This procedure,
by reducing the immunogenicity of the
normal alloantigens on the surface of
SAL cells, facilitates the response to
tumnour antigens. This serum bound to
(1) the membrane of viable SAL cells but
not to any normal cells from August rats;
(2) the membrane of all cells normal and
malignant-of Hooded phenotype. The
fact that after absorption on normal
Hooded cells this serum no longer com-
bined with intact SAL cells indicates that
the only tumour specific surface antigen
of SAL which is detected by this sera cross
reacts with a Hooded antigen. We have
not been able to demonstrate that SAL
cells have any additional tumour-specific
membrane antigens which do not cross-
react with Hooded alloantigens.
(b) Serum from Wistar rats immunized
with normal Hooded rat tissue and then
absorbed with normal August cells bound
to the membrane of SAL cells but not to
normal August cells. Absorption of this
serum with SAL cells did not abolish its
reactivitywith normal Hooded cells. This
is to be expected since it is probable that
there should be several alloantigenic
differences between Hooded and August
cells.
(c) Serum from August rats immunized
with mitomycin-C treated SAL cells was
absorbed only with Wistar macrophages
to remove putative immune complex and
aggregated Ig. This serum bound to
SAL cells and to Hooded cells but not to
normal August tisses. Absorption on
SAL cells abolished its activity against
Hooded cells. This isagain consistentwith
the concept that the tumour-specific
membrane antigen of SAL cross-reacts
with an antigen present on the membrane
of normal Hooded cells.
Living SAL cells stained at 4°C with
all these antisera show a very fine speckled
appearance. The bound immunoglobulin
caps when the temperature is raised to
37°C and capping is complete in 40 min
when incubated with both the antibody
and conjugate.
The measurement of migration inhibi-
tion (see Table III) by the 2 alloantisera
is consistent with the hypothesis that the
tumour-specific antigen on SAL is serolo-
gically identical to a membrane compon-
ent present in normal thymocytes of
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Hooded phenotype. Thymocytes were
used as these behaved very reproducibly
in the migration assay but this test cannot
be used to establish the widespread
representation of this antigen on diffei'ent
types of Hooded cells.
DISCUSSION
Both the serological data and the
indcuction of resistance by immunization
with allogeneic Hooded cells suggest that
the August rat leukaemia SAL carries on
its membrane a determinant, the " Ho-
SAL antigen ", which operationally be-
haves like a tumour-specific transplanta-
tion-type antigen (TSTA) to which the
synigeneic host responds. Yet in the
syngeneic situation immunization with
SAL cells that have been rendered incapa-
ble of cell division by a variety of treat-
ments induces a degree of host resistance
which is very much less than that follow-
ing immunization with cells of Hooded
phenotype (i.e. compare Table I and
data in Wrathmell and Alexander, 1976).
The fact that August rats but not
AugustxHooded F1 hybrids can be im-
munized with Hooded cells against the
syngeneic SAL leukaemia provides strong
support for the view that the TSTA on
SAL cross-reacts with an antigen ofnormal
Hooded cells. Why then are Hooded
cells much more immunogenic than SAL
cells? We are clearly not dealing with a
genetic defect (e.g. anIr gene deficit) which
prevents the August rat from responding
to Ho-SAL, as is the case for some mouse
strains which fail to react to the strong
leukaemia-related antigen, X-1 (Sato
et al., 1973). Two mechanisms which
are not mutually exclusive can be envis-
aged: (1) response to the Ho-SAL antigen
requires the presence of another antigen,
as was found to be the case for the TSTA
of E.L.4. leukaemia cells (Gorer and
Amos, 1946) and for certain non-H-2
transplantation antigens (Sanderson,
1964); (2) x-irradiation, and to a lesser
extent treatment with mitomycin-C, may
impair the immunogenicity of SAL with
respect to the Ho-SAL antigen, as has
been suggested for the TSTA ofcertain rat
sarcomata (Proctor, Rudenstam and
Alexander, 1974; Wrathmell and Alexan-
der, 1976).
Ho-SAL has a formal similarity to
TL, Glx and MM antigens in that they
are tumour specific in some strains but
are normal alloantigens in others. Ho-
SAL, however, differs from these mouse
antigens in, (1) being expressed not only
on normal lymphoid cells but on other
cells of Hooded phenotype; (2) not pro-
ducing cytotoxic antibodies. Glx and
MM are closely related to oncogenic
viruses and are probably coded by viral
genes present in the genome of most mice
but only phenotypically expressed by
some. There is no indication for a viral
association of the Ho-SAL antigen at
present and the biological basis for its
selective expression based on phenotype
remains to be determined. Experiments
are in progress to determine whether the
So-SAL antigen or other SAL-associated
antigen is present on the membrane of
other August rat tumours.
This investigation has been supported
by Funds from the Leukaemia Research
Fund and one of us (C. L. Gauci) is a
Research Fellow of the Cancer Research
Campaign.
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